KELSEY STOCKER: Open Payments
NPI 1750006375 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 11 payments from 8 companies in 2025. Trend: 2023 $610 · 2024 $521 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. | 1 | $213 |
| Incyte Corporation | 2 | $153 |
| ABBVIE INC. | 1 | $149 |
| Janssen Biotech, Inc. | 1 | $144 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| SANOFI-AVENTIS U.S. LLC | 1 | $38 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: Optune Lua (NovoTTF-200T), Niktimvo, RYBREVANT, Fabhalta, REZUROCK, Vanflyta.
Industry payments across NY — which companies pay providers there.
